| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |